R-Pharm US Operating LLC
Records under this name other than the patents R-Pharm US Operating LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to R-Pharm US Operating LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,871,227 | Process and formulation containing epothilones and analogs thereof Term ended Term ended Dec 28, 2025 · From the USPTO record | Term ended | Term ended Dec 28, 2025 | From the USPTO record |
| US 7,932,031 | Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1 Term ended Term ended Nov 29, 2025 · From the USPTO record | Term ended | Term ended Nov 29, 2025 | From the USPTO record |
| US 7,767,432 | Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B Term ended Term ended Mar 21, 2025 · From the USPTO record | Term ended | Term ended Mar 21, 2025 | From the USPTO record |
| US 8,598,215 | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases Term ended Term ended Mar 15, 2025 · From the USPTO record | Term ended | Term ended Mar 15, 2025 | From the USPTO record |
| US 7,312,237 | Combination of Epothilone Analogs and Chemotherapeutic Agents for the Treatment of Proliferative Diseases Term ended Term ended Aug 21, 2024 · High confidence | Term ended | Term ended Aug 21, 2024 | High confidence |
| US 7,241,899 | Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B Term ended Term ended Jul 26, 2024 · High confidence | Term ended | Term ended Jul 26, 2024 | High confidence |
| US RE42,191 | Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B Term ended Term ended Sep 22, 2023 · From the USPTO record | Term ended | Term ended Sep 22, 2023 | From the USPTO record |
| US 7,022,330 | Parenteral Formulation for Epothilone Analogs Term ended Ended no later than Jun 13, 2022 · Medium confidence | Term ended | Ended no later than Jun 13, 2022 | Medium confidence |
| US RE41,393 | Treatment of refractory tumors using epothilone derivatives Term ended Term ended Feb 8, 2022 · From the USPTO record | Term ended | Term ended Feb 8, 2022 | From the USPTO record |
| US RE40,387 | Pharmaceutical Compositions, Dosage Forms and Methods for Oral Administration of Epothilones Term ended Term ended Jan 25, 2022 · Low confidence | Term ended | Term ended Jan 25, 2022 | Low confidence |